Cannabidiol, more commonly called CBD, is the cannabinoid where most studies have been focused for years, the purpose is to demonstrate its effectiveness on the human body in combating various disorders: the fields of investigation most involved in studies mainly concern the treatment of cancer, psychosis and its potential as an anti-convulsant substance. However, the properties of CBD have also been recognized to counter various other disorders, including Alzheimer's disease, diabetes, skin diseases, dystonia and hypertension.
In January 2016, the study by Dr. Leweke was confirmed by Neuropsychopharmacology demonstrating the anti-psychotic properties of CBD. The journal Neuropsychopharmacology supported Leweke's study also stating that it appears to have no additive side effects or a lethal dose. It has also been announced by the British bio-pharmaceutical industry GW Pharmaceuticals that tests have begun on a new CBD-based drug against schizophrenia symptoms. Another study, this time conducted by researchers at the University of Medicine of Sao Paulo and published in the journal Fundamental & Clinical Pharmacology has shown on mice that CBD can reduce and in some cases block the symptoms ofobsessive compulsive disorders.
Speaking about addictions, we can say that researchers at the Psychopharmacology Unit of the University College of London have demonstrated the effectiveness of CBD in fighting nicotine addiction; Another study published by the monthly Pharmacology Biochemistry and Behavior has shown that CBD can be used to eliminate alcohol-induced brain damage, and researchers at Mount Sinai School of Medicine of New York have discovered that it can be used to prevent steatosis liver disease, which can lead to cirrhosis and hepatitis, since CBD prevents the accumulation of fat in the liver due to alcohol. Researchers at the Department of Pharmacology at the King-Faisal University of Al-Ahsa have said that cannabidiol can also protect the liver tissue from the damaging effects of cadmium (a toxic chemical element that can lead to renal dysfunction). Finally, weconclude with the study carried out by researchers at the Department of Psychology of the University of Haifa, who said that CBD may represent a new approach for cognitive deficits that accompany depression and other neuropsychiatric disorders related to anxiety and stress.